Favipiravir is used in treatment of Covid-19 patients. We aimed in this case report to share of ocular surface fluorescence in a patient after Favipiravir treatment.
A 20 years-old male ,with no medical history, applied to us with blurry vision and blue light reflection after Covid-19 treatment with Favipiravir. We observed bilateral fluorescence on his eyes and fluorescence of his nails. Biomicroscopic examination was insignificant.
We investigated the fluorescence of favipiravir tablets under ultraviolet light. Drug demonstrated fluorescence. We recorded the favipiravir fluorescence independently of the patient. This is strong evidence that the fluorescence of the patient’s ocular surface and favipiravir are linked.